» Articles » PMID: 21805160

Profound and Persistent Decrease of Circulating Dendritic Cells is Associated with ICU-acquired Infection in Patients with Septic Shock

Overview
Specialty Critical Care
Date 2011 Aug 2
PMID 21805160
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Septic shock induces a decrease in dendritic cells (DCs) that may contribute to sepsis-induced immunosuppression. We analyzed the time course of circulating DCs in patients with septic shock and its relation to susceptibility to intensive care unit (ICU)-acquired infections.

Methods: We enrolled adult patients with septic shock (n = 43), non-septic shock (n = 29), and with sepsis without organ dysfunction (n = 16). Healthy controls (n = 16) served as reference. Blood samples were drawn on the day of shock (day 1), then after 3 and 7 days. Myeloid (mDC) and plasmacytoid (pDC) DCs were counted by flow cytometry. Cell surface HLA-DR expression was analyzed in both DC subsets.

Results: At day 1, median mDC and pDC counts were dramatically lower in septic shock patients as compared to healthy controls (respectively, 835 mDCs and 178 pDCs/ml vs. 19,342 mDCs and 6,169 pDCs/ml; P < 0.0001) but also to non-septic shock and sepsis patients (P < 0.0001). HLA-DR expression was decreased in both mDCs and pDCS within the septic shock group as compared to healthy controls. DC depletion was sustained for at least 7 days in septic shock patients. Among them, 10/43 developed ICU-acquired infections after a median of 9 [7.5-11] days. At day 7, mDC counts increased in patients devoid of secondary infections, whereas they remained low in those who subsequently developed ICU-acquired infections.

Conclusion: Septic shock is associated with profound and sustained depletion of circulating DCs. The persistence of low mDC counts is associated with the development of ICU-acquired infections, suggesting that DC depletion is a functional feature of sepsis-induced immunosuppression.

Citing Articles

Immunoadjuvant therapy in the regulation of cell death in sepsis: recent advances and future directions.

Islam M, Watanabe E, Salma U, Ozaki M, Irahara T, Tanabe S Front Immunol. 2024; 15:1493214.

PMID: 39720718 PMC: 11666431. DOI: 10.3389/fimmu.2024.1493214.


The role of trained immunity in sepsis.

Wang W, Ma L, Liu B, Ouyang L Front Immunol. 2024; 15:1449986.

PMID: 39221248 PMC: 11363069. DOI: 10.3389/fimmu.2024.1449986.


Optimal Timing of PD-1/PD-L1 Blockade Protects Organ Function During Sepsis.

Xiang J, Wang Y, Shi L, Qiu J, Gan L, Xu Z Inflammation. 2024; .

PMID: 39174864 DOI: 10.1007/s10753-024-02113-3.


The potential immunological mechanisms of sepsis.

Zhang X, Zhang Y, Yuan S, Zhang J Front Immunol. 2024; 15:1434688.

PMID: 39040114 PMC: 11260823. DOI: 10.3389/fimmu.2024.1434688.


Immunotherapy in the context of sepsis-induced immunological dysregulation.

Wu Y, Wang L, Li Y, Cao Y, Wang M, Deng Z Front Immunol. 2024; 15:1391395.

PMID: 38835773 PMC: 11148279. DOI: 10.3389/fimmu.2024.1391395.


References
1.
Mermel L, Farr B, Sherertz R, Raad I, OGrady N, Harris J . Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32(9):1249-72. DOI: 10.1086/320001. View

2.
Efron P, Martins A, Minnich D, Tinsley K, Ungaro R, Bahjat F . Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis. J Immunol. 2004; 173(5):3035-43. DOI: 10.4049/jimmunol.173.5.3035. View

3.
Caille V, Chiche J, Nciri N, Berton C, Gibot S, Boval B . Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock. Shock. 2004; 22(6):521-6. DOI: 10.1097/01.shk.0000143410.63698.57. View

4.
Rittirsch D, Flierl M, Ward P . Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008; 8(10):776-87. PMC: 2786961. DOI: 10.1038/nri2402. View

5.
Tinsley K, Grayson M, Swanson P, Drewry A, Chang K, Karl I . Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J Immunol. 2003; 171(2):909-14. DOI: 10.4049/jimmunol.171.2.909. View